Soya isoflavones: genistein and daidzein are increasingly consumed in Western countries. Their beneficial effects are discussed considering nutrition and health in Asia. The present study aimed to check whether chronic ingestions, ethnic origin and dietary context can influence soya phyto-oestrogen bioavailability. Two prospective trials were carried out to blindly assess the pharmacokinetics after acute and chronic intake of soya-based cheese (45·97 (SD1·57) mg isoflavones) taken once a day for 10 d. Twelve healthy young Asians immersed for 2 months in France were randomised in a cross-over design to compare the influence of a Western v. Asian dietary context. The second trial partly nested in the first one, compared Asians under the Western diet to twelve healthy young male Caucasians under the same diet. All volunteers were non-equol producers. After an acute intake of soya in Western diet, Asians exhibited higher maximum concentration measured in plasma (C max ) and area under the plasma concentration -time curve (AUC) for genistein and daidzein than Caucasians (P¼ 0·005, 0·006, 0·032 and 0·008, respectively). In Caucasians under Western diet, AUC and C max values significantly increased after chronic intake. This was not the case for daidzein in Asians whatever the dietary context. For the first time, it is evidenced that on acute intake of soya cheese, Asians absorb soya phyto-oestrogens better than Caucasians, regardless of whether the background diet is Western or Asian. On chronic ingestions, AUC and C max values were increased for daidzein and genistein in Caucasians but not in Asians. There are ethnical differences in isoflavone pharmacokinetic and bioavailability. This may influence health outcomes.
Genistein and daidzein are phyto-oestrogens interacting with oestradiol receptors and highly concentrated in soybeans. The current interest in these isoflavones has resulted in a significant number of publications on their potential efficacy in improving welfare and health. However, much data on their consumption and their bioavailability are still lacking even though several reviews exist on their bioavailability (1 -3) . Soya products are traditionally used in many Asian countries. In Japan, the mean total intake of isoflavones is estimated between 39 and 47·2 mg/d (4 -6) . In China, the mean intake was evaluated at 17·7 mg/d (7) or at 25·4 mg/d (8) . In Korea, the soya isoflavone intake was estimated at 20·9 mg/d (9) . In contrast, in Western countries, daily isoflavone intake was evaluated at , 2 mg (10) . However, clinical studies were often performed on Westerners using high isoflavone intake from 10 mg up to 240 mg/d (11 -13) with a current exposure between 60 and 100 mg (1) . Isoflavone concentrations in the plasma of Asians under a traditional diet were found to be higher than those of non-Asians under their traditional diet (14) . However, to date, no study has assessed the influence of ethnic origin either on the bioavailability or on the pharmacokinetics of isoflavones. The ethnic origin was shown to influence the bioavailability of dietary components either via inter-ethnic genetic differences (15) or gut flora interethnic differences (16) . Over the past 10 years, Westerners have been increasingly exposed to soya isoflavones through the consumption of soya food or isoflavone supplements (17) . Nevertheless, the knowledge of isoflavone pharmacokinetics especially on chronic ingestions is required to determine an appropriate intake of soya isoflavones, and allow health professionals to give appropriate advice. Recent reviews have dealt with several factors influencing the bioavailability of isoflavones (3, 18) . The effect of chronic soya exposure is still controversial.
Several data showed metabolism adaptation and others did not (19 -22) . Traditional Asian food is considered to be different from Western food (23) and responsible for specific health characteristics. To our knowledge, no studies comparing the effects of either Asian or Western background diets on the pharmacokinetics of soya isoflavones have so far been conducted.
This clinical trial investigates for the first time whether: (i) ethnicity (Asian v. Caucasian); (ii) once only v. chronic soya exposure or (iii) background diet may influence isoflavone pharmacokinetics of the main soya isoflavones.
Methods
Twelve French Caucasian and twelve Chinese Asian healthy young male volunteers were recruited. Most of the Asians were visiting students and had been in France for 2 months when the experiment began. Subjects were interviewed in their native language on their usual dietary preferences. Asians were mainly on a traditional Asian diet served at the school restaurant with the agreement of dieticians. They could also have Asian or Western food from a takeaway restaurant collaborating with the study with the agreement of dieticians, and consumed in the subjects' private accommodation. Caucasians were invited to follow their usual Western dietary habits currently proposed at the French school restaurant and checked by dieticians. Volunteers were mainly non-smokers (nineteen out of twenty-four, four smokers among Caucasian volunteers). None of the smokers had more than ten cigarettes per day, and they were asked not to consume alcohol and to keep on with their usual physical activities. Cigarette consumption was maintained in order not to modify liver metabolism just before the study. All subjects were aged between 20 and 30 years old, with a BMI between 19·4 and 25·5 kg/m 2 ( Table 1) . The protocol was explained to subjects in their native language and they provided written informed consent. The previous medical history of the volunteers was checked as well as their current health status. A biological blood test was performed to check for digestive, liver or kidney disease. Exclusion criteria were any digestive, liver or kidney pathologies, excessive cigarette or drug consumption, and excessive alcohol, coffee or tea consumption. Secondarily, equol production became an exclusion criterion to homogenise the volunteer population. The subjects had to abstain from consuming any drugs, especially antibiotics, for at least 30 d before the beginning of the study and during it. Subjects were not authorised to consume soya-containing foods for 10 d before the study and until its completion. This was carefully checked with school restaurants and takeaway restaurants involved in the study. Moreover, the main foods containing polyphenols, such as red fruits, red wine, chocolates, tea or coffee, were prohibited for 3 d before the beginning of the study, and during the study. Items consumed all through the study are summarised in Table 2 with the main characteristics of the diets.
The study was performed at the Clinical Investigation Center (INSERM and Bordeaux University Hospital, HautLevêque Hospital, Pessac, France) and approved on 28 April 2004 by the regional Medical Ethics Committee (Comité Consultatif pour la Protection des Personnes se prêtant à des Recherches Biomédicales, CCPPRB A, Bordeaux, France). The present study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects/patients were approved by the CCPPRB A, Bordeaux, France. Written informed consent was obtained from all subjects.
Two interventional comparative trials of 10-d soya-based cheese administration were carried out. The first trial was a randomised, two-way cross-over design with an 18-d washout period that assessed the influence of the dietary context, i.e. Western or Asian, on isoflavone pharmacokinetics in Asian subjects (Fig. 1, right side) . The second trial assessed the influence of ethnic origin by blindly comparing isoflavone pharmacokinetics in Caucasians and Asians under a Western diet (Fig. 1 ). These two trials were nested in one design allowing the participation of Asians in both trials at once. Moreover, it allowed the comparison of isoflavone pharmacokinetics in each ethnic group under its usual diet. Caucasians were divided at random into two groups participating in the experiment at two different periods of time to improve their comparability with Asians with regard to the time period of the experimentation. Isoflavone plasma levels and pharmacokinetics were determined blind to the ethnic origin and the nature of the dietary context. Each volunteer received a 56 g portion of a soya-based cheese daily for 10 d, associated either with a traditional Western or a traditional Asian diet according to the trial. As mentioned earlier, diets previously composed by dieticians were provided either by the school restaurant or by a takeaway restaurant collaborating with the study. Soya-based-cheeses were from Le Sojami w (Agen, France). The soya-based cheese contained 45·97 (SD 1·57) mg of isoflavones in aglycone equivalent, (genistein: 25·45 (SD 0·85) mg; and daidzein: 20·51 (SD 0·80) mg). This was checked at the beginning of the trial, at mid-time and at the end. Isoflavones were mainly in the glycosylated form (. 95 %) as assed by a double ELISA assay with or without hydrolysis of the samples (see below for hydrolysis procedure and sample treatments). Meals eaten in the hospital unit were all identical and checked by a dietician. During the 10-d-periods out of the hospital, subjects were provided with pre-prepared meals from the takeaway restaurant or from the school restaurant with recipes approved by dieticians and complying with the specific dietary recommendations based on the age and sex of the subjects and the specific protocol. Table 2 presents the main characteristics of each type of diet.
In both trials, a baseline of 10 ml blood sample was collected before soya food ingestion (T 0 ). Furthermore, blood samples were collected after 4, 6, 8, 10, 12, 18 and 24 h. Plasma samples were centrifuged at 5000 g for 5 min at 48C and stored frozen at 2 208C until analysis. Isoflavone concentrations in blood samples were measured by ELISA as previously described (11, 24, 25) . Briefly, before assay, plasmas were first hydrolysed using b-glucuronidase -arylsulphatase (Roche Diagnostic, Mannheim, Germany) for 24 h at 378C in acetate buffer 0·05 M, pH 5. After hydrolysis, plasmas were extracted using three times, three volumes of acidified ethyl acetate. Solvent was evaporated to dryness and the extract was resuspended in an assay buffer by sonication. ELISA is a competitive assay using immobilised antigen as the competitor. Specificity tests demonstrated that none of the antibodies recognised equol or O-desmethylangolensin, dihydrodaidzein and dihydrogenistein significantly (i.e. , 0·3 % in all cases). In addition, a good parallelism was observed between standard curves and plasma dilution curves (26) , showing that no cross-reaction with plasma metabolites could alter genistein or daidzein measurements in plasmas. Any of the conjugates is recognised by any of our antibodies. The method was validated against HPLC (20) and was previously used for isoflavone pharmacokinetic measurements in human subjects (27, 28) , giving results in accordance with previous studies performed using other assay methods. Pharmacokinetic parameters were obtained using the pharmacokinetic software PK-FIT version 1.2 (RDPP, Montpellier, France). Non-compartmental pharmacokinetic analysis was used to analyse plasma isoflavone concentration -time data. The parameters of maximum concentration (C max ), and time for maximum concentration (T max ), were obtained from experimental observations without interpolation. The terminal slope (K e ) of the concentration -time curve was determined by loglinear regression. Elimination half-life (t 1/2 ) of the terminal log-linear phase was calculated following the equation 0·693/K e . The area under the plasma concentration -time curve (AUC) was extrapolated to infinity (AUC 1 ) or was calculated on a 24 h basis (AUC 24 h ). AUC were determined by trapezoidal and log-trapezoidal methods summing the areas from time 0 to the time of the last time taken into consideration (t) with or without an extrapolation from t to infinity (AUC 1 ). The extrapolated area was determined by dividing the last detectable concentration by the slope of the terminal log-linear phase. To ensure that comparisons were valid in the parallel controlled studies, C max , AUC 24 h and AUC 1 values for daidzein and genistein were adjusted to the individual body weight (BW).
In the tables, data are expressed as means and standard deviations. For AUC 24 h , the number of data is twelve. Comparisons of all parameters were performed on paired Wilcoxon signed-rank tests when comparing day 1-10, and by Wilcoxon rank-sum tests for other, non-paired comparisons. The effect of the dietary context on the pharmacokinetic parameters of each isoflavone in Asians was studied using a cross-over analysis where intra-subject comparisons were based on paired Wilcoxon signed-rank tests. It followed the strategy proposed by Grizzle (29) . Interaction between dietary context and intake period was first studied. If significant at a nominal significance level 0·10 (bilateral analysis), the comparison of dietary contexts should have been only used for the first intake period. Otherwise, comparisons of dietary contexts were to be performed using the two intake periods. Except for interaction analysis in the cross-over strategy, all tests were considered statistically significant at P, 0·05. All analyses were performed with Statistical Analysis Systems Software version 9.2 (SAS Institute, Cary, NC, USA).
Results
Some data were withdrawn from some analyses because in a few cases, the compliance of the subjects to the protocol was not complete. An Asian volunteer did not present for plasma sampling at day 11, and a second at day 12. One Caucasian and four Asians had hidden soya in a sauce during the second kinetic evaluation of one or the other trials, as discovered while analysing dietary records and plasmas. The analyses were still possible since only one, two or three sets of data were lost at the maximum (see figures and tables for number of datasets used). During the hospital phase, the compliance was total and all the data obtained on the first 24 h could be integrated. In each case, it was considered that the results would be greater impaired if the defecting set of data was kept than if it was removed.
Effect of ethnicity, Asian v. Caucasian, on plasma isoflavone pharmacokinetics under Western diet Fig. 2 shows the plasma concentrations time course after acute and chronic ingestions in these cases n 12. Table 3 reports AUC 24 h , AUC 1 , C max , t 1/2 and T max computed from the individual plasma concentration for both ethnic groups. For AUC 1 , T max and t 1/2 values were withdrawn when the dietary protocol was not strictly followed. This is mentioned in the tables' headings.
Acute ingestion. Following the acute ingestion of soyabased cheese in a Western dietary context, the AUC 24 h and C max for both daidzein and genistein were significantly higher in Asians than in Caucasians. For daidzein, AUC were 29·2 (SD 11·2) v. 19·6 (SD 6·1) ng/ml per h per kg BW for Asians and Caucasians, respectively; and C max were 2·9 (SD 1·1) v. 1·7 (SD 0·5) ng/ml per kg BW for Asians and Caucasians, respectively (AUC 24 h , P¼0·008 and C max , P¼0·006). For genistein, AUC were 43·7 (SD 15·5) v. 30·1 (SD 9·8) ng/ml per h per kg BW for Asians and Caucasians, respectively. C max were 3·7 (SD 1·1) v. 2·4 (SD 0·7) ng/ml per kg BW for Asians and Caucasians, respectively (AUC 24 h , P¼0·032 and C max , P¼0·005). In addition, in both ethnic groups, serum concentrations had not returned to baseline concentrations 24 h after isoflavone ingestion (Fig. 2) .
Chronic ingestions. Daidzein and genistein concentrations in plasma were not nil at T 0 of day 10 (Fig. 2) . They progressively returned to baseline 72 h after the last intake. At day 10, daidzein AUC 24 h and C max were still significantly higher in Asians (AUC 24 h : 32·5 (SD 11·5) v. 25·6 (SD 5·3) ng/ml per h per kg BW for Asians and Caucasians, respectively; P¼0·0032) (C max : 2·9 (SD 1·1) v. 1·7 (SD 0·5) ng/ml per kg BW for Asians and Caucasians, respectively; P¼0·03). At day 10, genistein C max were the only parameter to be significantly higher in Asians (4·5 (SD 1·6) v. 3·2 (SD 1·2) ng/ml per kg BW for Asians and Caucasians, respectively; P¼0·05).
Comparisons between acute and chronic ingestions. A 10-d period of isoflavone intake significantly increased AUC 24 h , AUC 1 and C max of genistein in Caucasian volunteers (P¼0·003, 0·01 and 0·01, respectively). For daidzein, differences were significant for AUC 24 h and AUC 1 (P¼0·04 and 0·002, respectively), and C max were insignificantly different (P¼0·08). In Asians, genistein AUC 24 h , AUC 1 and C max were increased (P¼0·004, 0·007 and 0·01, respectively), but not those of daidzein.
Effect of the dietary context, Asian v. Western diet, on plasma isoflavone pharmacokinetics in Asian volunteers
No significant interaction between period and dietary context was observed, except for the T max of genistein after chronic ingestions (P¼0·06).
Pharmacokinetic parameters are summarised in Table 4 and curves are presented in Fig. 3 .
Acute ingestion. Daidzein AUC 24 h were significantly higher in Asians under an Asian diet (40·8 (SD 15·6) v. 29·2 (SD 11·2) ng/ml per h per kg BW for Asian and Western diets, respectively; P¼0·003), and genistein AUC 24 h were significantly lower (33·3 (SD 10·6) v. 43·7 (SD 15·5) ng/ml per h per kg BW for Asian and Western diets, respectively; P¼0·02). This was sustained by differences in T max (P¼0·04).
Chronic ingestions. There were no differences between the dietary contexts for any of the parameters considered.
Comparisons between acute and chronic ingestions. Genistein AUC 24 h , AUC 1 and C max were increased in subjects on a Western diet (P¼0·005, 0·007 and 0·01, respectively). This is not the case for daidzein. An increase in AUC 24 h and AUC 1 was also seen for genistein in Asians under an Asian diet (P¼0·003 and 0·02, respectively), but not for C max . For daidzein, the only parameters that were increased under acute ingestion were AUC 1 . (P¼0·02) and t 1/2 (P¼0·03).
Comparison between ethnic groups each under its own diet
Pharmacokinetic parameters are exposed in Table 5 and curves are presented in Fig. 4 .
Acute ingestion. Only daidzein AUC 24 h were higher in Asians under an Asian diet (40·8 (SD 15·6) v. 19·6 (SD 6·1) ng/ml per h per kg BW for Asians and Caucasians, respectively; P¼0·0003). No differences were recorded for genistein.
Chronic ingestions. Both AUC 24 h and AUC 1 of daidzein were higher in Asians under an Asian diet than in Caucasians under a Western diet (AUC 24 h : 38·5 (SD 13·3) v. 25·6 (SD 5·3) ng/ml per h per kg BW for Asians and Caucasians, respectively; P¼ 0·009 and AUC 1 : 49·9 (SD 23·8) v. 33·5 (SD 11·1) ng/ml per h per kg BW for Asians and Caucasians, respectively; P¼0·04). C max were not different. For genistein, no differences were recorded.
Comparisons between acute and chronic ingestions. In Caucasians under a Western diet, AUC 24 h , AUC 1 and C max values of genistein all increased significantly (P¼0·003, 0·01 and 0·01, respectively), whereas only AUC 24 h and AUC 1 values increased in Asians under an Asian diet (P¼0·002 and 0·02, respectively). C max were not increased in Asians after chronic intakes. In Caucasians, AUC 24 h and AUC 1 of daidzein were significantly increased (P¼0·04 and 0·002, respectively) sustained by an insignificant increase in C max and t 1/2 (P¼0·08 for both). This increase was not noticed for Asians under an Asian diet. Only AUC 1 was increased (P¼0·02), sustained by a significant increase in t 1/2 (P¼0·03).
Discussion

Study design
For the first time, the pharmacokinetics of isoflavones were compared between two ethnic groups in the same periods, in the same study using a homologous assay method. As far as we know, it is the first time that the effect of a dietary context was examined for its ability to modify the pharmacokinetics of isoflavones, and it is the first time that isoflavones pharmacokinetics were compared after acute and chronic ingestions. We included healthy young male subjects in order to avoid the interaction with oestrogens that can occur in women (30, 31) . The experimentation was carried out over two distinct periods of time separated by a wash-out period of 18 d, using the cross-over design for the assessment of the role of dietary context in Asians. Caucasians were also divided at random into two groups, to be studied during the same periods of time to 9·6  3·1  0·42  14·2  8·5  12·5  4·3  0·89  0·58 AUC 24 h , area under the time -concentration curve calculated on a 24 h basis; AUC 1 , AUC extrapolated to infinity; C max , maximum concentration measured in plasma; T max , time at which C max is measured; t 1/2 , half-life period. For all AUC 24 h , n 12.
Statistical analysis was performed according to a cross-over analysis strategy (see text), except for AUC 24 h comparisons. All intra-subject comparisons were based on paired Wilcoxon signed-rank tests. * Differences are significant for P,0·05.
improve the comparability with their Asian counterparts (Fig. 1) . For practical reasons, the wash-out period was fixed at 18 d since at least seven t 1/2 are required. Recent data have mentioned t 1/2 durations over 25 h (27, 28, 32) . We chose to chronically expose volunteers for a 10-d duration since 10-d adaptation phenomena had already been registered for carbohydrates (33) . There were great differences in the individual weight of volunteers, so the pharmacokinetic parameters were adjusted to this parameter to reduce its impact on the inter-individual variations. Daidzein concentrations in plasma were lower than those of genistein due to respective concentrations of both compounds in soya-based cheese and to a shorter plasma residence time for daidzein (27, 28, 34, 35) . AUC 24 h were always lower than AUC 1 . This meant that at 24 h, the elimination process was far from over. In some cases, differences were seen on AUC 24 h and were not on AUC 1 ; this can be explained because some volunteers exhibited recirculation phenomena after 24 h. Indeed, it was shown by other authors that, after passing the gut wall, isoflavones are sent to the liver for the first step of conjugation. A portion of the compounds are metabolised as bile compounds and return to the gut. Once in the gut, they can re-enter the bloodstream via the enterocyte uptake. These phenomena increased the residence time in the blood and therefore the area under the curve. This recirculation did not appear in all volunteers. As a consequence, this raised the standard deviation about the mean values of AUC 1 leading to a decrease in significance. None of the volunteers presented an equol production as tested using the specific ELISA previously set up (11, 20, 25) . This reduced the inter-individual variability of pharmacokinetic parameters. Indeed, as shown in a previous paper, equol production modifies the bioavailability of daidzein (27, 28) .
Effect of ethnicity, Asian v. Caucasian, on plasma isoflavone pharmacokinetics under Western diet
The values of pharmacokinetic parameters fitted with previous data from other authors (3, 27, 28, 34) validating the relevancy of the assay methods.
Acute ingestion. The higher values of AUC 24 h and C max obtained in Asians indicate that Asians better absorb isoflavones than Caucasians on acute ingestion of isoflavones included in a soya-based cheese. The absorption efficiency may be different between ethnic groups since the T max and t 1/2 two parameters influenced by the speed of absorption and elimination processes were similar.
Chronic ingestions. After 10 d of chronic ingestions, differences were reduced for daidzein since the AUC and C max increased more in Caucasians than in Asians. For genistein, it was the same and only C max remained higher in Asians.
Comparisons between acute and chronic ingestions. The absence of increases in the combination of AUC 24 h , AUC 1 and C max of daidzein in Asians was unexpected. Indeed, because t 1/2 varies from 6 to 24 h for daidzein and genistein (27, 28, 32) , it was expected to find isoflavones in plasmas collected at T 0 of day 10 and to observe an increase in AUC 24 h , AUC 1 and C max values. This was true for genistein and for daidzein in Caucasians, but not for daidzein in Asians (Table 3) . This may indicate a modification of the daidzein enzymatic pathways involved in pharmacokinetic phenomena in these specific conditions. This observation was linked to a diminution of T max , suggesting a shorter absorption process. This is possibly due to an interaction of the Western food with the gut wall and flora. In Asian and Caucasian women, it was shown that gut transit time depending on diet can influence urine isoflavone excretion (36) . Daidzein is the only compound to be influenced after a 10-d period of chronic ingestion, probably as a result of its shorter residence time in plasma.
Effect of dietary contexts in Asians
Acute ingestion. No statistical differences appeared when parameters were compared for daidzein or genistein in one or the other dietary contexts, except when AUC were calculated on a 24 h basis. However, in that case, the superiorities were inverted for the two isoflavones, values being higher in Asians under an Asian diet for daidzein and higher in Asians under a Western diet for genistein (Table 4) . Therefore, no significant impact of the dietary context on isoflavone bioavailability can be concluded from these data.
Chronic ingestions. Comparing the dietary context and after chronic ingestions, there were no longer differences in any of the parameters analysed, whatever the isoflavone considered. This leads to the conclusion that the pharmacokinetics of both daidzein and genistein delivered in soya-based cheese are not influenced by the dietary context in Asians.
Comparisons between acute and chronic ingestions. The expected increases in AUC and C max linked to long t 1/2 of the two isoflavones were only noticed for genistein.
For daidzein, whatever the dietary context there were no consistent increases in AUC and C max . This would suggest that a metabolic adaptation could occur in Asians after chronic ingestion of daidzein affecting the efficiency of daidzein absorption. Because t 1/2 were not affected, it can be hypothesised that this adaptation affects the absorption process and may take place at the gut level. It may be linked to a slight modification of the gut flora composition linked to the nature of the food item ingested.
Comparisons of ethnic groups under their own traditional diet
Classically, when Asians are compared to Westerners, this comparison includes both ethnic and dietary characteristics. Therefore, we compared the pharmacokinetics of each ethnic group on its own habitual diet. In these conditions, daidzein AUC were consistently higher in Asians than in Caucasians when each was on their traditional food and whatever the exposure duration: acute intake or ten chronic intakes. This finding was sustained by previous data (36) obtained in Asian and Caucasian women challenged with higher doses of isoflavones. It was also observed that AUC 24 h , AUC 1 and C max for genistein and daidzein consistently increased in Caucasians after chronic ingestion, whereas it was not the case for daidzein and for genistein C max in Asians. This would suggest that under ten chronic ingestions, in these specific conditions (doses, rhythm of ingestion and food intake), Caucasians were able to experience an increase in AUC and C max , but not Asians. Because t 1/2 were never modified whatever the ethnic group or the dietary context, it could be suggested that the differences reported here may be linked to differences at the gut level. Indeed, when genetic differences between groups were observed in previous studies for other compounds, it was shown that t 1/2 were different (15, 18) . This indicates that, here, the endogenous enzymes involved in absorption, cell storage and elimination and which influence t 1/2 of isoflavones were probably not very different between Asians and Caucasians. At any rate, the inter-individual differences may have masked the inter-ethnic differences. If enzymes were not fundamentally different between the two ethnic groups, the difference in absorption could possibly be due to differences either in the background diet or in gut flora activity (37) . Indeed, gut flora is known to be influenced by the dietary context (3) and to influence isoflavone bioavailability (36, 37) . Moreover, a microflora difference between Asians and Caucasians was already hypothesised previously (36) , although never demonstrated as far as we know. The present study also showed that Caucasians experienced a greater increase in AUC 24 h , AUC 1 and C max of daidzein than Asians after ten chronic ingestions when each ethnic group was on its own traditional diet. If this phenomenon is maintained on longer exposure, it may lead to an accumulation in Caucasians and not in Asians. Therefore, on chronic daily exposure, Asians would have lower isoflavone plasma levels than Caucasians and this for a similar intake. This was already suggested by Gooderham & Adlercreutz (13) comparing their results to those obtained by Adlercreutz (14) . In both studies, the assay method and the isoflavone delivery were similar and the plasma levels were 371 (SD 93) and 107 ng/ml for Caucasians and Asians, respectively. Looking at the scattered literature produced either on Asians or on Caucasians, the effect observed in the present study seems to be confirmed. Indeed, several studies produced on Asians (38 -41) found isoflavone plasma levels of 185, 159 (SD 80), 219 (SD 330) and 148 ng/ml, respectively. In all these studies, volunteers were on traditional Asian diet (from 39 to 46·4 mg isoflavones/d). They were followed without fasting, and the blood sampling was performed in the morning between 10 and 12 h postingestion. At the same time in studies dealing with long-term exposure of Caucasians to isoflavones (11, 13, 42) , the isoflavones plasma levels were 371 (SD 93), 177 (SD 104) and 941 (SD 370) ng/ml for a daily intake of 45, 10 and 100 mg of isoflavone, respectively. This time again the delay between isoflavone intake and plasma collection was between 10 and 12 h.
Conclusion
The present manuscript provides evidence that on acute intake, Asians absorb isoflavones from soya cheese better than Caucasians, regardless of whether the background diet is Western or Asian. In Asians, the pharmacokinetics of isoflavones from soya-based cheese were not influenced by dietary context. Finally, chronic ingestions lead to a consistent increase in the AUC and C max of isoflavones in Caucasians under a Western diet, but this was not true for daidzein in Asians whatever the background diet, Asian or Western. This could have consequences on isoflavone bioavailability after chronic ingestions. A greater understanding of isoflavone pharmacokinetics could strengthen some hypothesis so far on a variety of potential health outcomes.
